Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.63 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.61 |
| ▸ | PTPRB | P23467 | 1/20 | 0.59 |
| ▸ | CDC25A | P30304 | 1/20 | 0.59 |
| ▸ | CDC25B | P30305 | 1/20 | 0.59 |
| ▸ | PTEN | P60484 | 1/20 | 0.59 |
| ▸ | PTPMT1 | Q8WUK0 | 1/20 | 0.59 |
| ▸ | DRD2 | P14416 | 1/20 | 0.57 |
| ▸ | DRD1 | P21728 | 1/20 | 0.57 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.57 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.55 |
| ▸ | IDO1 | P14902 | 1/20 | 0.54 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.54 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.52 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.51 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31336237 | 1.00 | KEAP1 (0.63) | KEAP1FFAR1PTPRBCDC25ACDC25B | |
| SCHEMBL29563859 | 1.00 | KEAP1 (0.63) | KEAP1FFAR1PTPRBCDC25ACDC25B | |
| Phenyl Propionic Acid SCHEMBL29282176 | 0.96 | KEAP1 (0.70) | KEAP1FFAR1PTPRBCDC25ACDC25B | |
| SCHEMBL30825091 | 0.93 | FFAR1 (0.56) | KEAP1FFAR1PTPRBCDC25ACDC25B | |
| Sulfuric Acid SCHEMBL18729778 | 0.93 | FFAR1 (0.55) | KEAP1FFAR1PTPRBCDC25ACDC25B | |
| SCHEMBL29185406 | 0.93 | FFAR1 (0.56) | KEAP1FFAR1PTPRBCDC25ACDC25B | |
| SCHEMBL3717612 | 0.89 | HDAC6 (0.66) | KEAP1FFAR1DRD2DRD1TAAR1 | |
| SCHEMBL70271 | 0.87 | KEAP1 (0.74) | KEAP1FFAR1PTPRBCDC25ACDC25B | |
| SCHEMBL1049248 | 0.87 | HDAC6 (0.67) | DRD2DRD1TAAR1HDAC6 | |
| SCHEMBL30303107 | 0.87 | HDAC6 (0.67) | DRD2DRD1TAAR1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1047 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| EP-4646452-A1 | FLAME RETARDANT COPOLYMER WITH ONE OR MORE NON-VIRGIN FOSSIL COMPONENTS AND METHODS OF MAKING THE SAME | Indorama Ventures Public Company Ltd (TH) | 2025-11-12 | — | — | EP | claimed |
| CN-119985745-A | Detection method for micromolecular phenolic substances and application thereof | 北京中医药大学 | 2025-05-13 | — | — | CN | claimed |
| CN-119936223-A | Metabolic marker for diagnosing or monitoring gastric cancer, screening method and application thereof | 武汉迈特维尔医学科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| CN-113009122-B | Methods and systems for determining the risk of autism spectrum disorder | 美国控股实验室公司 | 2025-01-17 | — | — | CN | claimed |
| CN-119291059-A | Screening method for metabolic markers for distinguishing non-colorectal cancer diseases from colorectal cancer and application of screening method | 哈尔滨脉图精准技术有限公司 | 2025-01-10 | — | — | CN | claimed |
| US-20240369563-A1 | BIOMARKER COMBINATION FOR ASSESSING RISK OF ADENOMA AND COLORECTAL CANCER, AND USE THEREOF | HUMAN METABOLOMICS INSTITUTE, INC. (CN) | 2024-11-07 | — | — | US | claimed |
| WO-2024178621-A1 | USE OF COMPOUNDS IN PREVENTING AND/OR TREATING OBESITY OR NAFLD | Westlake University (CN) | 2024-09-06 | — | — | WO | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| WO-2011002995-A1 | PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHODS OF MAKING AND USE THEREOF | KEMPHARM, INC. (US) | 2011-01-06 | — | — | WO | claimed |
| US-20110002991-A1 | PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHOD OF MAKING AND USE THEREOF | ALTER DOMUS (US) LLC | 2011-01-06 | — | — | US | claimed |
| WO-2010118241-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-10-14 | — | — | WO | claimed |
| WO-2010097412-A1 | IONIC LIQUID SOLVENTS | DUBLIN CITY UNIVERSITY (IE) | 2010-09-02 | — | — | WO | claimed |
| EP-2223915-A1 | Ionic liquid solvents | Dublin City University (IE) | 2010-09-01 | — | — | EP | claimed |
| US-7452938-B2 | Aqueous resin composition, aqueous coating material containing the composition, coating provided by the material, and metal plate coated with the material | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2008-11-18 | — | — | US | claimed |
| US-20030199566-A1 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | BIONUTRIGEN CO., LTD. (KR) | 2003-10-23 | — | — | US | claimed |
| US-4994273-A | Solubility modulated drug delivery device | MERCK & CO., INC. (US) | 1991-02-19 | — | — | US | claimed |
| US-4946686-A | Solubility modulated drug delivery system | MERCK & CO., INC. (US) | 1990-08-07 | — | — | US | claimed |
| EP-0193475-A1 | Process for the acetoacetylation of aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1986-09-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199566-A1 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | NCEH1, HMGCR, DBH | KEAP1 155/4885FFAR1 301/4885PTPRB 3107/4885 |
| US-20110002991-A1 | PHENYLETHANOIC ACID, PHENYLPROPANOIC ACID AND PHENYLPROPENOIC ACID CONJUGATES AND PRODRUGS OF HYDROCODONE, METHOD OF MAKING AND USE THEREOF | CYP7A1, CYP2B6, CYP2D6 | KEAP1 836/4885FFAR1 307/4885PTPRB 1473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.